<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The overall objective of the Canadian Collaborative Cohort of Related <z:hpo ids='HP_0000726'>Dementias</z:hpo> (ACCORD) study is to describe the diagnostic distribution, natural history and treatment outcomes of individuals referred from the community to <z:hpo ids='HP_0000726'>dementia</z:hpo> clinics in Canada </plain></SENT>
<SENT sid="1" pm="."><plain>Between 1997 and 1999, an inception cohort of 1,136 subjects entered into this longitudinal study </plain></SENT>
<SENT sid="2" pm="."><plain>At the baseline assessment, 10.9% of the subjects were classified as "not cognitively impaired" (NCI), 30.1% as "cognitively impaired not <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e>" (CIND), and 59% as <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A subclassification of CIND included amnestic 25.1%, vascular <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> 18.1%, psychiatric 17.2%, neurologic 7.3%, medical/toxic metabolic 3.5%, mixed 7.6% and not specified 19.0% </plain></SENT>
<SENT sid="4" pm="."><plain>The percentage of the cohort referred with <z:hpo ids='HP_0000726'>dementia</z:hpo> increased progressively each decade, while the proportions of CIND and NCI decreased </plain></SENT>
<SENT sid="5" pm="."><plain>Within the <z:hpo ids='HP_0000726'>dementia</z:hpo> group, <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> accounted for 47.2% of the subjects, mixed <z:hpo ids='HP_0000726'>dementias</z:hpo> 33.7%, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> 8.7%, frontotemporal degenerations 5.4%, <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> 2.5%, and unclassifiable 1.8% </plain></SENT>
<SENT sid="6" pm="."><plain>The ACCORD cohort will allow a detailed study of the longitudinal course of CIND, and the longer-term outcomes of both treated and untreated <z:hpo ids='HP_0000726'>dementia</z:hpo> subjects </plain></SENT>
</text></document>